AnheuserBusch InBev Shares Dip on Sales Miss Market Cautious Government Plans Up to 2 Stake Sale in LIC Potentially Raising Rs 10000 Crore SpaceX OpenAI and Anthropic IPOs Could Test the Limits of the AI Boom SpaceX OpenAI and Anthropic IPOs Could Test Limits of AI Boom as Founders Vie for Wall Street Capital US Jobless Claims Remain Low Signaling Labor Market Resilience ixigo Partners with Uber and redBus to Integrate Cab and Bus Bookings in Train App 908 Devices MASS Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher Northern Trust Q1 2026 Earnings Strong EPS Beat Driven by Fee Income and Expense Discipline Seneca Foods Corp SENEA Q1 2026 Earnings Robust EPS Despite Limited Guidance Context Seacoast Banking Corporation of Florida SBCF Q1 2026 Earnings EPS Beats Estimates Amid Steady Net Interest Margin Flexible Solutions International FSI Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises Unexpectedly STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances The GrowHub Limited TGHL Gains 356 Approaching Key Resistance Level BBCQU Units Trade Nearly Flat at 1189 as SPAC Consolidates Near Support John Wiley Sons WLY Sees Modest Uptick as Shares Test Resistance Near 4465 Wyndham Hotels Stock Slips Amid Broader Market Pressure Key Levels to Watch Evolution Petroleum EPM Gains 123 as Shares Test Key Resistance Level CIOs Turn to Business Users for Vibe Coding A New Era of Enterprise App Development TGS Q1 2026 Earnings Earnings Smash Estimates Amidst Energy Sector Dynamics LB Pharmaceuticals Inc LBRX Edges Higher Amid Sector Strength Key Levels in Focus VRRM Q1 2026 Earnings EPS Beats Estimates by 318 Shares Rise 727 VOYG Q1 2026 Earnings EPS Misses Estimates but Stock Surges 11 on Investor Optimism RCT Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines INFU Q1 2026 Earnings EPS Surpasses Estimates by 466 Shares Dip Slightly EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline MPLT Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline NNOX Q4 2025 Earnings Significant EPS Miss as PreRevenue Stage Continues